Label: MUCINEX SINUS MAX SINUS PRESSURE SEVERE CONGESTION- oxymetazoline hci spray

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 16, 2025

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredient
    Oxymetazoline hydrochloride 0.05%

    Purpose:

    Nasal Decongestant

    Uses:

    ■ temporarily relieves nasal congestion due to:
    ■ a cold
    ■ hay fever or other upper respiratory allergies
    ■ promotes nasal and/or sinus drainage; temporarily
    relieves sinus congestion and pressure
    ■ helps clear nasal passages; shrinks swollen membranes

  • PURPOSE

    Purpose:

    Nasal Decongestant

  • WARNINGS


    Warnings
    Ask a doctor before use if you have
    ■ heart disease

    ■ high blood pressure
    ■ thyroid disease

    ■ diabetes
    ■ difficulty in urination due to enlargement of the
    prostate gland


    When using this product
    ■ do not exceed recommended dosage
    ■ do not use this product for more than 3 days. Use
    only as directed. Frequent or prolonged use may
    cause nasal congestion to recur or worsen.
    ■ this product may cause temporary discomfort such
    as burning, stinging, sneezing, or an increase in
    nasal discharge
    ■ the use of this container by more than one person
    may spread infection

    Stop use and ask a doctor if symptoms persist

  • DOSAGE & ADMINISTRATION


    Directions
    ■ adults and children 6 to under 12 years of age (with
    adult supervision): 2 or 3 sprays in each nostril, not
    more often than every 10 to 12 hours. Do not exceed
    2 doses in any 24-hour period.
    ■ children under 6 years of age: consult a doctor.


    Shake well before use.
    To open, hold by the white grips then squeeze, push down
    firmly and turn cap counterclockwise. Before using for the
    first time, remove the protective cap from the tip and
    prime metered pump by depressing firmly several times.
    To spray, hold bottle with thumb at the base and nozzle
    between first and second fingers.Without tilting head,
    insert nozzle into nostril. Fully depress pump all the way
    down with a firm even stroke and sniff deeply.

    Wipe nozzle clean after use. To
    close, turn cap clockwise.
    DO NOT DISCARD CAP.

  • PREGNANCY OR BREAST FEEDING


    If pregnant or breast-feeding, ask a health professional
    before use.

  • KEEP OUT OF REACH OF CHILDREN


    Keep out of reach of children. If swallowed, get medical
    help or contact a Poison Control Center right away.

  • OTHER SAFETY INFORMATION


    Other information
    ■ store at 20-25°C (68-77°F)

  • INACTIVE INGREDIENT


    Inactive ingredients
    benzalkonium chloride,
    benzododecinium chloride,
    cetalkonium chloride, dibasic
    sodium phosphate anhydrous,
    edetate disodium, glycerin,
    monobasic sodium phosphate
    anhydrous, myristalkonium
    chloride, phosphorous pentoxide,
    propylene glycol, purified water,
    sodium oxide, sorbitol

  • QUESTIONS


    Questions?
    1-866-MUCINEX (1-866-682-4639)


    Dist. by: RB Health (US)
    Parsippany NJ 07054-0224

  • PRINCIPAL DISPLAY PANEL

    Label

  • INGREDIENTS AND APPEARANCE
    MUCINEX SINUS MAX SINUS PRESSURE SEVERE CONGESTION 
    oxymetazoline hci spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72854-219
    Route of AdministrationNASAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE0.05 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    BENZODODECINIUM CHLORIDE (UNII: Y5A751G47H)  
    PHOSPHORUS PENTOXIDE (UNII: 51SWB7223J)  
    CETALKONIUM CHLORIDE (UNII: 85474O1N9D)  
    SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    MYRISTALKONIUM CHLORIDE (UNII: 0W255OL75T)  
    SODIUM OXIDE (UNII: 3075U8R23D)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SORBITOL (UNII: 506T60A25R)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (UNII: 3980JIH2SW)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72854-219-111 in 1 CARTON06/01/2025
    122 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01206/01/2025
    Labeler - RB Health (US) LLC (081049410)